Hikma Pharmaceutical | HIK - Loan Capital

Stock Price
1,373.00
Daily Change
-279.00 -16.89%
Monthly
-11.13%
Yearly
-37.08%
Q1 Forecast
1,600.34

Hikma Pharmaceutical reported $798M in Loan Capital for its fiscal semester ending in June of 2025.





Loan Capital Change Date
Almirall EUR 324.81M 61.32M Dec/2025
argenx SE USD 35.57M 3.05M Jun/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Autolus Therapeutics Ltd USD 244.63M 8.81M Jun/2025
Bayer EUR 32.71B 1B Sep/2025
Fresenius EUR 10.8B 1.49B Sep/2025
Galapagos EUR 5.76M 290K Sep/2025
Genmab DKK 126M 6M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
GRIFOLS EUR 9.09B 1.64B Sep/2025
Hikma Pharmaceutical USD 798M 191M Jun/2025
Lonza CHF 4.24B 602M Dec/2024
Merck EUR 10.45B 4.15B Sep/2025
Orion EUR 129.6M 6.4M Sep/2025
Recordati EUR 2.18B 89.51M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025
UCB EUR 2.82B 146M Jun/2025